Endogenous Melatonin and Epileptogenesis: Facts and Hypothesis

References

• Abilio V. C., Freitas F. M., Dolnikoff M. S., Castrucci A. M. L., Frussa-Filho R. Effects of continuous exposure to light on behavioral dopaminergic supersensitivity. Biological Psychiatry 1999; 45: 1622–1629
   PubMedGoogle Scholar
• Adachi A., Suzuki Y., Nogi T., Ebihara S. The relationship between ocular melatonin and dopamine rhythms in the pigeon: effects of melatonin on dopamine release. Brain Research 1996; 815: 435–440
   Google Scholar
• Alam A. M., Starr M. S. Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology 1996; 35(2)159–167
   PubMedGoogle Scholar
• Anlezark G., Marrosu F., Meldrum B. Dopamine agonists in reflex epilepsy. Neurotransmitters, Seizures and Epilepsy, P. L. Morselli, K. G. Lloyd, W. Loscher, B. Meldrum, E. H. Reynolds. Raven Press, New York 1981; 251–259
   Google Scholar
• Anton-Tay F. Melatonin: effects on brain function. Advances in Biochemistry and Psychopharmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Arida R. M., Scorza F. A., de Araujo Peres C., Cavalheiro E. A. The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Research 1999; 34: 99–107
   PubMed Web of Science ®Google Scholar
• Avoli M., Gloor P. Effects of transient functional depression of the thalamus on spindles and on bilateral synchronous epileptic discharges of feline generalized penicillin epilepsy. Epilepsia 1981; 22: 443–452
   PubMedGoogle Scholar
• Barone P., Palme V., De Bartolomeis A., Cicarelli G., Campanella G. Dopaminergic regulation of epileptic activity. Neurochemistry International 1992; 20: 249S–245S
   Google Scholar
• Birkeland A. J. Plasma melatonin levels and nocturnal transitions between sleep and wakefulness. Neuroendocrinology 1982; 34: 126–131
   PubMed Web of Science ®Google Scholar
• Borowicz K. K., Kaminski R., Gasior M., Kkinrok Z., Czuczwar S. J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. European Neuropsychopharmacology 1999; 9: 185–190
   PubMedGoogle Scholar
• Castillo Romero J. L., Vives Montero F., Acuna Castroviejo D. Paradoxical effects of melatonin on spontaneous neuronal activity in the striatum of sham operated and pinealectomized rats. Journal of Pineal Research 1992; 12(4)149–154
   PubMedGoogle Scholar
• Cox B., Lomax P. Brain amines and spontaneous seizures in the Mongolian gerbil. Pharmacology Biochemistry and Behavior 1976; 4: 263–267
   PubMedGoogle Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience and Biobehavioral Reviews 1980; 4(4)451–458
   PubMedGoogle Scholar
• Deransart C., Vercueil L., Marescaux C., Depaulis A. The role of the basal ganglia in the control of generalized absence seizures. Epilepsy Research. 1998; 32: 213–223
   PubMedGoogle Scholar
• El-Hamdi G., Boutroy M. J., Nehlig A. Effects of pentylenetetrazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat. International Journal of Developmental Neuroscience 1992; 10: 301–311
   PubMedGoogle Scholar
• Fukada M., Niwa S. -I., Kumagai N., Nagakubo S., Hashimoto O., Shirayama Y., Hata A., Kameyama T., Anzai N. Plasma homovanillic acid levels in temporal lobe epilepsy. Journal of Epilepsy 1998; 11: 383–388
   Google Scholar
• Gatterau A., Vezina J., Rousseau S., Bielmann P. Hyperprolactineamia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief. Journal of Endocrinology Investigation. 1990; 13: 247–249
   PubMedGoogle Scholar
• Gillette M. U. Cellular and biochemical mechanisms underlying circadian rhythms in vertebrates. Current Opinion in Neurobiology 1997; 7: 797–804
   PubMed Web of Science ®Google Scholar
• Hamdi A. Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum. Life Sciences 1998; 63(23)2115–2120
   PubMedGoogle Scholar
• Hara M., Sasa M., Kawabata A., Serikawa T., Yamada T., Yamada J., Takaon S. Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat. Epilepsia 1993; 34: 433–440
   PubMedGoogle Scholar
• Hellier J. L., Dudek F. E. Spontaneous motor seizures in rats with kainiteinduced epilepsy: effect of time of day and activity state. Epilepsy Research 1999; 35: 47–57
   PubMed Web of Science ®Google Scholar
• Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry 1996; 153(4)460–476
   Google Scholar
• Manev H., Uz T., Kharlamov A., Joo J. -Y. Increased brain damage after stroke or excitotoxic seizures melatonin-deficient rats. FASEB Journal. 1996; 10: 1546–1551
   PubMed Web of Science ®Google Scholar
• Mevissen M., Ebert U. Anticonvulsant effects of melatonin in amygdala-kindled rats. Neuroscience Letters 1998; 257: 13–16
   PubMed Web of Science ®Google Scholar
• Miguez J. M., Martin F. J., Aldegunde M. Melatonin effects on serotonin synthesis and metabolism on the striatum, nucleus accumbens, and dorsal and median raphe nuclei of the rat. Neurochemical Research 1997; 22(1)87–92
   PubMedGoogle Scholar
• Moore R. Y. Neural control of the pineal gland. Behavioural Brain Research. 1996; 73: 125–130
   PubMed Web of Science ®Google Scholar
• Monteleone P., Tortorella A., Bordello R., Natale M., Cassandro P., Maj M. Suppression of nocturnal melatonin levels by evening administration of sodium valproate in healthy humans. Biological Psychiatry. 1998; 41: 336–341
   Google Scholar
• Mori A., Hiramatsu M., Namba S., Nishimoto A., Ohmoto T., Mayanagi Y., Asakura T. Decreased dopamine level in the epileptic focus. Research Communications in Chemical Pathology and Pharmacology 1987; 56(2)157–64
   PubMedGoogle Scholar
• Munoz-Hoyos A., Sanchez-Forte M., Molin-Carballo A., Escames G., Martin-Medina E., Reiter R. J., Molina-Font J. A., Acuna-Castroviejo D. Melatonin's role as an anticonvulsant and neuronal protector: experimental and clinical evidence. Journal of Child Neurology 1998; 13: 501–509
   PubMedGoogle Scholar
• Ninchoji T., Uemura K., Shimoyama I. Effect of pinealectomy on cortically kindled rats. Epilepsy Research 1990; 7: 240–244
   PubMedGoogle Scholar
• Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., Morita Y. Differential pattern of circadian rhythm of serum melatonin in young and elderly healthy subjects. Biological Signals 1997; 6: 301–306
   PubMedGoogle Scholar
• Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., Morita Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biological Psychiatry 1999; 45: 1646–1652
   PubMed Web of Science ®Google Scholar
• Sandyk R., Tsagas N., Anninos P. A. Melatonin as a preconvulsive hormone in humans. International Journal of Neuroscience 1992; 63: 125–135
   PubMed Web of Science ®Google Scholar
• Shouse M. N., Martins da Silva A., Sammaritano M. Circadian rhythm, sleep and epilepsy. Journal of Clinical Neurophysiology 1996; 13: 32–50
   PubMed Web of Science ®Google Scholar
• Sperk G., Lassmann H., Baran H., Kish S. J., Seitelberger F., Hornykiewicz O. Kainic acid-induced seizures: neurochemical and histopathological changes. Neuroscience 1983; 10: 1301–1315
   PubMed Web of Science ®Google Scholar
• Stankov B., Reiter R. J. Melatonin receptors: current status, facts, and hypotheses. Life Sciences 1990; 46: 971–982
   PubMedGoogle Scholar
• Starr M. S. The role of dopamine in epilepsy. Synapse 1996; 22: 159–194
   PubMed Web of Science ®Google Scholar
• Tenn C. C., Niles L. P. Mechanisms underlying the antidopamtnergic effect of Clonazepam and melatonin in the striatum. Neuropharmacology 1995; 36(11–12)1659–1663
   Google Scholar
• Willis G. L., Armstrong S. M. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiology and Behavior 1999; 66(5)785–795
   PubMed Web of Science ®Google Scholar
• Ying S. -W., Rusak B., Delagrange P., Mocaer E., Renard P., Guardiola-Lemaitre B. Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. European Journal of Pharmacology 1996; 296: 33–42
   PubMed Web of Science ®Google Scholar
• Zisapel N. Melatonin receptors revisitEd. Journal of Neural Transmission 1988; 73: 1–5
   PubMedGoogle Scholar